INTRODUCING AMBU® SURESIGHT™ MOBILE VIDEO LARYNGOSCOPE
2.12.2025 13:36:10 CET | Ambu A/S | Press release
Following the launch of Ambu® SureSight™ Connect in the U.S. and Great Britain in the first half of 2025, Ambu now expands its video laryngoscope portfolio with Ambu® SureSight™ Mobile – a video laryngoscope with an integrated screen for emergent and unplanned intubations across clinical settings.

Today, Ambu announces the introduction of SureSight Mobile, a portable video laryngoscope solution that expands and brings next-level flexibility to Ambu’s video laryngoscope portfolio.
Designed to be robust, reliable, and durable, the SureSight Mobile features an integrated screen without the need for separate monitors or cables. This all-in-one design enables clinicians to perform emergent and unplanned intubations swiftly and confidently in demanding environments – whether in an ambulance, emergency room, or remote location – making the SureSight Mobile a solution targeted for both pre-hospital and hospital settings. This versatile solution delivers high-quality imaging, empowering clinicians to not only visualize the airway with clarity but also seamlessly document and review the intubation process.
"There is now overwhelming evidence that video laryngoscopy enhances both the safety and efficacy of tracheal intubation compared with direct laryngoscopy. The recently published DAS 2025 Intubation Guidelines recommend that video laryngoscopes be used as the first-line approach for tracheal intubation whenever feasible. The launch of the SureSight Mobile is therefore extremely timely, enabling universal access to video laryngoscopy for all intubations across the hospital environment."
DR. IMRAN AHMAD1
Consultant Anesthetist, Guy's & St Thomas' NHS Foundation Trust, London, UK
Expanding and leveraging Ambu’s video laryngoscope portfolio
In the U.S. alone, the video laryngoscope market represents roughly DKK 4 billion and is growing 15-20% annually. Today, around 50% of all endotracheal intubations are performed with a video laryngoscope, making it the preferred intubation method across clinical settings. To support this development, Ambu’s expanded video laryngoscope portfolio now offers two SureSight video laryngoscope solutions, including a comprehensive range of 10 blades of different sizes. The breadth of Ambu’s video laryngoscope portfolio ensures that clinicians have a SureSight video laryngoscope for every setting, scenario, and preference – obtaining flexibility, reliability, and confidence across the continuum of care.
Ambu will now engage in a controlled market release phase, collaborating with clinicians at key hospitals across the U.S. and Great Britain, to evaluate the performance of the SureSight Mobile in clinical settings. Subsequently, Ambu will engage in a full launch in 2026.
"With the launch of SureSight Mobile, Ambu is reinforcing our leadership in the Respiratory market. By expanding our portfolio with a mobile video laryngoscope solution, we are addressing the needs clinicians face during unexpected intubation – when time matters most. This innovation reflects our commitment to delivering a comprehensive Respiratory offering of advanced solutions that empower healthcare professionals to make fast, confident decisions and uphold the highest standards of care across clinical settings."
BRITT MEELBY JENSEN
Chief Executive Officer, Ambu
----------------------------------------------------------------------------------
1 Dr. Ahmad has not been compensated for his quote in this press release.
Keywords
Contacts
Anders HjortHead of Investor Relations
Tel:+45 2892 8881anhj@ambu.comTine Bjørn SchmidtDirector of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comABOUT AMBU
Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.
Subscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
AMBU ACQUIRES TIMS MEDICAL TO ADVANCE ENDOINTELLIGENCE14.9.2026 15:00:00 CEST | Press release
The acquisition expands Ambu's endoscopy offering with established hospital integration and workflow technology and access to around 7,000 installations across U.S. hospitals, accelerating the Company's EndoIntelligence™ agenda.
AMBU EXPANDS NEUROLOGY PORTFOLIO IN NORTH AMERICA AND EUROPE20.8.2026 09:00:00 CEST | Press release
Ambu expands its neurology portfolio with an EEG solution that supports continued brain monitoring during MRI/CT scans, following FDA clearance and CE marking for Ambu® Neuroline™ Cup MRI/CT.
AMBU APPOINTS HEAD OF INVESTOR RELATIONS18.8.2026 09:00:18 CEST | Press release
Lisa Bedell Clive brings 25 years of capital markets experience to Ambu, including two decades at leading investment research firm Bernstein covering the European MedTech sector.
AMBU RECIRCLE PROGRAM EXPANDS TO INCLUDE BIOPLASTIC SURESIGHT BLADES8.6.2026 08:35:17 CEST | Press release
By adding SureSight™ video laryngoscope blades to its recycling program, Ambu expands its take-back and recycling offering to further support hospitals in reducing waste.
AMBU SURESIGHT WINS RED DOT AWARD FOR PRODUCT DESIGN30.4.2026 10:49:45 CEST | Press release
International Red Dot jury recognizes the design excellence of Ambu’s newly launched video laryngoscope solution, SureSight™, emphasizing its coherent system architecture.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom